BARDA Proposes New Consortia For Rapid Pandemic Response
Executive Summary
The HHS agency hopes to bring together private sector teams that could quickly defend the US against future infectious outbreaks. The plan also calls for working with commercial lenders for the capital required to expand production of medical countermeasures.
You may also be interested in...
BARDA Releases Five-Year Strategic Plan
The Biomedical Advanced Research and Development Authority says lessons learned from the pandemic has better prepared the agency to respond to future health emergencies, including a new infectious disease division.
The Quality Lowdown: Blast From Past At Sun Mohali, Touch Of Future With IT/OT Integration
Ranbaxy consent decree is invoked again after the FDA’s latest inspection unveils backdating at Sun’s Mohali plant. FDA probes Intas plant’s many deceptions, Ipca stumbles on investigations without start dates and Sure-Biochem must admit missing client’s contamination.
How The US FDA Is Checking For Adequate Controls Against DEG/EG Ingredient Substitution
Agency has increased its efforts to protect the US market from the diethylene glycol and ethylene glycol adulteration linked to hundreds of deaths in seven countries with testing, remote records requests, inspections, import alerts and more. Manufacturing quality compliance director Francis Godwin stresses importance of testing every container, while sharing tips for simplifying the task.